Asensus Surgical Inc (ASXC)

[Lewrock]

Cantor Fitzgerald sticks their necks out with an overweight rating and a $1.50 target.

[Lewrock]

What level of revenue is needed to reach positive cash flow? I think the number is around $40 million. They have a long way to go!

[wochsac]

I doubt ASXC will be below $3 much longer

[wochsac]

might see ASXC robotics on Mars 1 day

[wochsac]

Lets see a nice GAP UP to $4 tomorrow

[wochsac]

SUPER BUY ASXC is an understatement

[EyalCap]

With placement in Japan and Russia last week we are moving up soon

[bwrbad]

SUPER BUY ASXC

Soon their SENHANCE surgical units are going to be in a number of US HOSPITALS side by side with Da Vinci. SENHANCE is the safest most sophisticated Robotic AI AR vision tracking surgical platform developed since Da Vinci came to market some 20 years ago.

[EyalCap]

Smells like a buy out will happen here soon if not def a M/A

[A1stockman]

Great news

[MDmojo]

Lets go!!!!

[Mindgame]

Go back to sleep. I am out.

[Mindgame]

Time for this puppy to wake up!!!!

[Frankestin]

https://www.cnbc.com/2021/06/08/senate-passes-bipartisan-tech-and-manufacturing-bill-aimed-at-china.html

[diskman]

$ASXC added to Russell 3000.

https://content.ftserussell.com/sites/default/files/russell_3000_index_additions_-_2021.pdf

[ClayTrader]

* * $ASXC Video Chart 06-04-2021 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $ASXC Video Chart 06-03-2021 * *

Link to Video - click here to watch the technical chart video

[weasel4339]

Any news?

[smoke_em]

Boom!

[NewbieViewbie]

Why do you say?

[smoke_em]

Holding 30,000 shares here. Big things to come!

[ClayTrader]

* * $ASXC Video Chart 05-26-2021 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $ASXC Video Chart 05-18-2021 * *

Link to Video - click here to watch the technical chart video

[NewbieViewbie]

Positive earnings is always good

[NewbieViewbie]

Earnings Tuesday... then up to $6 or back to $.60. Any ideas?

[ClayTrader]

* * $ASXC Video Chart 04-27-2021 * *

Link to Video - click here to watch the technical chart video

[doofus11]

say what? did you see what it did today? tomorrow same thing.. are you shorting? if so, you lost everything

[ClayTrader]

* * $ASXC Video Chart 04-26-2021 * *

Link to Video - click here to watch the technical chart video

[doomdevice]

Study showing significantly lower instrument costs than da Vinci with comparable learning curve and console times.

https://www.linkedin.com/posts/asensus-surgical-inc_digitallaparoscopy-senhance-roboticsurgery-activity-6790679507914252288-3j9t

In this real-world comparative assessment from four U.S. and European hospitals, results showed that the learning curve of gynecological Senhance®? surgeons compared to those of da Vinci gynecological surgeons achieved lower median instrument costs with comparable console times. Case costs between Senhance and laparoscopic-assisted vaginal hysterectomy cases were comparable as well. This further supports how Digital Laparoscopy with Senhance is reducing the economic limitations of current robotic systems so that the benefits of our technology can reach more patients.

Learn more about the assessment here:
https://pubmed.ncbi.nlm.nih.gov/33860631/

[ClayTrader]

* * $ASXC Video Chart 04-22-2021 * *

Link to Video - click here to watch the technical chart video

[agua77]

Yea sure bud that’s comical.

[ClayTrader]

* * $ASXC Video Chart 04-21-2021 * *

Link to Video - click here to watch the technical chart video

[doofus11]

My guess is they tried to bring it down to scare all of the investors. I kept buying as it went down all the way from $6 I now have 34k shares at an average of $3. This will be a $40 stock in a year or so. I feel a buy out is coming soon. Great time to buy the company before it goes back up to $20

[agua77]

No idea, apparently they beat it down enough to meet their need.

[lakingsphan0427]

Well this POS (at the moment) is up 27%.. What gives?

[NewbieViewbie]

Uh huh

[doofus11]

This is going to $5 by friday

[agua77]

One of the worse investments I’ve made.

[Exposeall]

Indeed

[lakingsphan0427]

Truly disaster since they changed their symbol.. So far its a POS

[lakingsphan0427]

This has become the biggest loser in my portfolio.. It's turning into a POS

[bwrbad]

ASXC is ready to take challenges - 10X -100X from current status - highend technology sophistication, superb flawless innovative intutive invasive surgery with minimal recovery time - human to robotics transformation. be part of it

[Adrock]

Let’s goooooooooooooo

[Adrock]

Let’s gooooo!!

[Balmighty87]

Great returns from a great investment.

[Vesig]

Good DD here

[Domino]

Just do proper due diligence.

This company has done its best to obfuscate their history and only product to cover up a horrid past and scam retail investors.

Asensus is the third name that this company is operating under. Their prior names were Transenterix and SafeStitch, both of which have never recorded a profit since inception as SafeStitch in 2005.

Each “company” has had just one product that was FDA approved under each company name and every one of them failed to generate a single dollar.

SAFESTITCH; Had a product named “SafeStitch” which was a Low Anterior Bowel Resection anastomotic device used for surgical intervention (cancer removal). It simplified the process of a purse-string suture technique that was time consuming. After FDA approval, this product was welcomed into the OR by general surgeons and did save time. Unfortunately, within months, patients were experiencing sepsis and many died due to a failure of the suture leading to anastomotic leaks.

TRANSENTERIX; Had FDA approval of their “SPYDER” RASD (Robtic Assisited Surgical Device) which proved to be cumbersome and lacking efficacy. It was shelved after a “No Sale” opinion from surgeons and hospitals. SURGIBOT; another RASD attempt that the FDA denied.
Telap-ALF X (Renamed Senhance) was created in 2003 by a nuclear research company that SOFAR thought may be viable in a OR setting. They found that it wasn’t and Todd Pope purchased the platform with shareholders money.

Asensus; Now continues with the same old product and a 3 year old employee that was promoted to CEO after Todd Pope and Joseph Slattery left the company two years ago.

Welcome Anthony Fernando, you were in charge of selling Senhance worldwide and you never registered a single commercial sale. Ever.

Go to PubMed (dot com) and research Telap ALF X and Senhance.

[Domino]

Just do proper due diligence.

This company has done its best to obfuscate their history and only product to cover up a horrid past and scam retail investors.

Asensus is the third name that this company is operating under. Their prior names were Transenterix and SafeStitch, both of which have never recorded a profit since inception as SafeStitch in 2005.

Each “company” has had just one product that was FDA approved under each company name and every one of them failed to generate a single dollar.

SAFESTITCH; Had a product named “SafeStitch” which was a Low Anterior Bowel Resection anastomotic device used for surgical intervention (cancer removal). It simplified the process of a purse-string suture technique that was time consuming. After FDA approval, this product was welcomed into the OR by general surgeons and did save time. Unfortunately, within months, patients were experiencing sepsis and many died due to a failure of the suture leading to anastomotic leaks.

TRANSENTERIX; Had FDA approval of their “SPYDER” RASD (Robtic Assisited Surgical Device) which proved to be cumbersome and lacking efficacy. It was shelved after a “No Sale” opinion from surgeons and hospitals. SURGIBOT; another RASD attempt that the FDA denied.
Telap-ALF X (Renamed Senhance) was created in 2003 by a nuclear research company that SOFAR thought may be viable in a OR setting. They found that it wasn’t and Todd Pope purchased the platform with shareholders money.

Asensus; Now continues with the same old product and a 3 year old employee that was promoted to CEO after Todd Pope and Joseph Slattery left the company two years ago.

Welcome Anthony Fernando, you were in charge of selling Senhance worldwide and you never registered a single commercial sale. Ever.

Go to PubMed (dot com) and research Telap ALF X and Senhance.

[Renee]

TransEnterix Inc., TRXC, changed to Asensus Surgical Inc., ASXC:

https://www.sec.gov/Archives/edgar/data/876378/000143774921005934/ex_233548.htm

[Domino]

“ Asensus Chief Executive Anthony Fernando said the FDA clearance will allow the Senhance system to be used in high-value surgeries, such as those used to treat reflux and obesity.”
————————————————————————————————————

Those surgeries would be a laparoscopic nissen fundoplication, gastric sleeve and Roux-en-y Gastric Bypass. All of these procedures require a surgical technique called counter traction.

With only 3 arms, Senhance is incapable of counter tracting, so my question is simple.

How are you going to do it?